{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:46:45Z","timestamp":1791121605868,"version":"4.1.0"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T00:00:00Z","timestamp":1369094400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0063597","type":"journal-article","created":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T17:19:54Z","timestamp":1369156794000},"page":"e63597","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":37,"title":["Comprehensive Genomic Characterization of Cutaneous Malignant Melanoma Cell Lines Derived from Metastatic Lesions by Whole-Exome Sequencing and SNP Array Profiling"],"prefix":"10.1371","volume":"8","author":[{"given":"Ingrid","family":"Cifola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pietrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa","family":"Consolandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Severgnini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Mangano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"De Bellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Battaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,5,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"R Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Orgaz JL, Sanz-Moreno V (2012) Emerging molecular targets in melanoma invasion and metastasis. Pigment Cell Melanoma Res.","DOI":"10.1111\/pcmr.12041"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1002011","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma","volume":"363","author":"KT Flaherty","year":"2010","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1038\/onc.2010.323","article-title":"Analysis of the genome to personalize therapy for melanoma","volume":"29","author":"MA Davies","year":"2010","journal-title":"Oncogene"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Sullivan RJ, Flaherty K (2012) MAP kinase signaling and inhibition in melanoma. Oncogene.","DOI":"10.1038\/onc.2012.345"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e28973","DOI":"10.1371\/journal.pone.0028973","article-title":"Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT\/mTOR pathway","volume":"6","author":"M Atefi","year":"2011","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.1158\/1078-0432.CCR-11-0098","article-title":"Glutamatergic pathway targeting in melanoma: single-agent and combinatorial therapies","volume":"17","author":"HJ Lee","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","article-title":"Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations","volume":"367","author":"KT Flaherty","year":"2012","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrg2841","article-title":"Advances in understanding cancer genomes through second-generation sequencing","volume":"11","author":"M Meyerson","year":"2010","journal-title":"Nat Rev Genet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ng.1026","article-title":"Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma","volume":"44","author":"SI Nikolaev","year":"2011","journal-title":"Nat Genet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ng.810","article-title":"Exome sequencing identifies GRIN2A as frequently mutated in melanoma","volume":"43","author":"X Wei","year":"2011","journal-title":"Nat Genet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ng.1041","article-title":"Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing","volume":"44","author":"MS Stark","year":"2011","journal-title":"Nat Genet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature11071","article-title":"Melanoma genome sequencing reveals frequent PREX2 mutations","volume":"485","author":"MF Berger","year":"2012","journal-title":"Nature"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","article-title":"A landscape of driver mutations in melanoma","volume":"150","author":"E Hodis","year":"2012","journal-title":"Cell"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1755-148X.2012.00975.x","article-title":"Reviewing the somatic genetics of melanoma: from current to future analytical approaches","volume":"25","author":"K Dutton-Regester","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"J Barretina","year":"2012","journal-title":"Nature"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nature11005","article-title":"Systematic identification of genomic markers of drug sensitivity in cancer cells","volume":"483","author":"MJ Garnett","year":"2012","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature05610","article-title":"Patterns of somatic mutation in human cancer genomes","volume":"446","author":"C Greenman","year":"2007","journal-title":"Nature"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1158\/0008-5472.CAN-06-4152","article-title":"Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays","volume":"67","author":"M Stark","year":"2007","journal-title":"Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"H Davies","year":"2002","journal-title":"Nature"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1038\/sj.onc.1210410","article-title":"Role of mitogen-activated protein kinase kinase 4 in cancer","volume":"26","author":"AJ Whitmarsh","year":"2007","journal-title":"Oncogene"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/prca.201000006","article-title":"Proteome profiling of immortalization-to-senescence transition of human breast epithelial cells identified MAP2K3 as a senescence-promoting protein which is downregulated in human breast cancer","volume":"4","author":"M Jia","year":"2010","journal-title":"Proteomics Clin Appl"},{"key":"ref23","first-page":"839","article-title":"Regulation of ERK3\/MAPK6 expression by BRAF","volume":"29","author":"KP Hoeflich","year":"2006","journal-title":"Int J Oncol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/ng.438","article-title":"Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4","volume":"41","author":"TD Prickett","year":"2009","journal-title":"Nat Genet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"7319","DOI":"10.1158\/0008-5472.CAN-06-4625","article-title":"Oncogenic activity of epidermal growth factor receptor kinase mutant alleles is enhanced by the T790M drug resistance mutation","volume":"67","author":"N Godin-Heymann","year":"2007","journal-title":"Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/path.1681","article-title":"Analysis of ovarian cancer cell lines using array-based comparative genomic hybridization","volume":"205","author":"MB Lambros","year":"2005","journal-title":"J Pathol"},{"key":"ref27","first-page":"21","article-title":"Oncogenic mutations of PIK3CA in human cancers","volume":"347","author":"Y Samuels","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e5717","DOI":"10.1371\/journal.pone.0005717","article-title":"Combined targeting of BRAF and CRAF or BRAF and PI3K effector pathways is required for efficacy in NRAS mutant tumors","volume":"4","author":"BS Jaiswal","year":"2009","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1681\/ASN.2010070701","article-title":"Glutamatergic signaling maintains the epithelial phenotype of proximal tubular cells","volume":"22","author":"M Bozic","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1471-2407-11-220","article-title":"Aberrant methylation of N-methyl-D-aspartate receptor type 2B (NMDAR2B) in non-small cell carcinoma","volume":"11","author":"H Tamura","year":"2011","journal-title":"BMC Cancer"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00428-010-1013-6","article-title":"Promoter CpG island hypermethylation during breast cancer progression","volume":"458","author":"SY Park","year":"2011","journal-title":"Virchows Arch"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"15605","DOI":"10.1073\/pnas.0507679102","article-title":"NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth","volume":"102","author":"A Stepulak","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/ng.950","article-title":"Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma","volume":"43","author":"TD Prickett","year":"2011","journal-title":"Nat Genet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1755-148X.2008.00452.x","article-title":"Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation","volume":"21","author":"SS Shin","year":"2008","journal-title":"Pigment Cell Melanoma Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuropharm.2005.05.018","article-title":"Grm5 expression is not required for the oncogenic role of Grm1 in melanocytes","volume":"49","author":"YE Marin","year":"2005","journal-title":"Neuropharmacology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1158\/0008-5472.CAN-06-3665","article-title":"Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma","volume":"67","author":"J Namkoong","year":"2007","journal-title":"Cancer Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"10300","DOI":"10.1158\/0008-5472.CAN-08-3272","article-title":"Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma","volume":"68","author":"DA Solomon","year":"2008","journal-title":"Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.ajpath.2011.11.038","article-title":"The nonreceptor-type tyrosine phosphatase PTPN13 is a tumor suppressor gene in non-small cell lung cancer","volume":"180","author":"M Scrima","year":"2012","journal-title":"Am J Pathol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbrc.2010.11.071","article-title":"Galectin-3 binding protein promotes cell motility in colon cancer by stimulating the shedding of protein tyrosine phosphatase kappa by proprotein convertase 5","volume":"404","author":"YS Kim","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nrc2228","article-title":"Emerging roles of proteases in tumour suppression","volume":"7","author":"C Lopez-Otin","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"E2148","DOI":"10.1002\/humu.21477","article-title":"Analysis of the disintegrin-metalloproteinases family reveals ADAM29 and ADAM7 are often mutated in melanoma","volume":"32","author":"X Wei","year":"2011","journal-title":"Hum Mutat"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1158\/1541-7786.MCR-10-0262","article-title":"Mutational and functional analysis reveals ADAMTS18 metalloproteinase as a novel driver in melanoma","volume":"8","author":"X Wei","year":"2010","journal-title":"Mol Cancer Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/sj.onc.1209767","article-title":"Identification of a tumor suppressive critical region mapping to 3p14.2 in esophageal squamous cell carcinoma and studies of a candidate tumor suppressor gene, ADAMTS9","volume":"26","author":"PH Lo","year":"2007","journal-title":"Oncogene"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1242\/jcs.050468","article-title":"The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer","volume":"122","author":"A Moncada-Pazos","year":"2009","journal-title":"J Cell Sci"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1242\/jcs.005751","article-title":"The ADAMTS12 metalloproteinase exhibits anti-tumorigenic properties through modulation of the Ras-dependent ERK signalling pathway","volume":"120","author":"M Llamazares","year":"2007","journal-title":"J Cell Sci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1038\/onc.2010.49","article-title":"Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesis","volume":"29","author":"M El Hour","year":"2010","journal-title":"Oncogene"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"D&apos;Abaco GM, Ng K, Paradiso L, Godde NJ, Kaye A, <etal>et al<\/etal>.. (2006) ADAM22, expressed in normal brain but not in high-grade gliomas, inhibits cellular proliferation via the disintegrin domain. Neurosurgery 58: 179\u2013186; discussion 179\u2013186.","DOI":"10.1227\/01.NEU.0000192363.84287.8B"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/ijc.24023","article-title":"Promoter hypermethylation of the ADAM23 gene in colorectal cancer cell lines and cancer tissues","volume":"124","author":"JS Choi","year":"2009","journal-title":"Int J Cancer"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1038\/sj.onc.1208952","article-title":"ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation","volume":"24","author":"H Takada","year":"2005","journal-title":"Oncogene"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrd3320","article-title":"G protein-coupled receptors: novel targets for drug discovery in cancer","volume":"10","author":"R Lappano","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1002\/cncr.24394","article-title":"The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers","volume":"115","author":"D Oka","year":"2009","journal-title":"Cancer"},{"key":"ref52","first-page":"1796","article-title":"Galanin, galanin receptors and drug targets","volume":"65","author":"K Mitsukawa","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1038\/sj.onc.1203777","article-title":"The galanin receptor type 2 initiates multiple signaling pathways in small cell lung cancer cells by coupling to G(q), G(i) and G(12) proteins","volume":"19","author":"N Wittau","year":"2000","journal-title":"Oncogene"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1038\/sj.onc.1210384","article-title":"Galanin and galanin receptor type 1 suppress proliferation in squamous carcinoma cells: activation of the extracellular signal regulated kinase pathway and induction of cyclin-dependent kinase inhibitors","volume":"26","author":"T Kanazawa","year":"2007","journal-title":"Oncogene"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/nn1345","article-title":"Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain","volume":"7","author":"ES Anton","year":"2004","journal-title":"Nat Neurosci"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0092-8674(00)00197-5","article-title":"EphB receptors interact with NMDA receptors and regulate excitatory synapse formation","volume":"103","author":"MB Dalva","year":"2000","journal-title":"Cell"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/nrc2761","article-title":"Mucins in cancer: function, prognosis and therapy","volume":"9","author":"DW Kufe","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng1151","article-title":"Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells","volume":"34","author":"MH Cheok","year":"2003","journal-title":"Nat Genet"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nm.2074","article-title":"Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses","volume":"16","author":"EJ Villablanca","year":"2010","journal-title":"Nat Med"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1755-148X.2012.00976.x","article-title":"Delving into somatic variation in sporadic melanoma","volume":"25","author":"V Walia","year":"2012","journal-title":"Pigment Cell Melanoma Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0063597","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T20:54:17Z","timestamp":1563051257000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0063597"}},"subtitle":[],"editor":[{"given":"Sumitra","family":"Deb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,5,21]]},"references-count":60,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0063597","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,21]]}}}